Ultrasensitive immunoassays have launched an explosion of research on blood biomarkers for a variety of neurological indications, spanning acute conditions such as traumatic brain and spinal cord injury to chronic conditions including multiple sclerosis, neurodegenerative disease, and dementia.

This webcast will focus on neurology blood biomarker research, highlighting Canadian assets that can be leveraged toward analytical and clinical validation studies. You will learn:

• How ultra-sensitivity allows for greater depth of exploration in neurological research
• Which immunoassays are currently most prevalent in neurological research
• The analytical and clinical validation process and how to use ultrasensitive immunoassays to achieve it

WATCH RECORDING